Winokur P, Hegmann TE, El Sahly HM, Anderson EJ, et al. A Phase 1 Double-Blinded Trial to Evaluate Safety, Immunogenicity, and Dosing of Measles-Vectored Chikungunya Virus Vaccine (MV-CHIK) in Healthy Adults. J Infect Dis 2025 Nov 28:jiaf571. doi: 10.1093.
PMID: 41313671